ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

HU

Hospital Universitario de Navarra at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Universitario de Navarra takes part in 8 sessions at ESMO 2026 in Madrid. Its program centres on precision treatment and access to care in gastrointestinal and genitourinary cancers. It examines barriers that keep people with high-risk bladder cancer from receiving immunotherapy after surgery.

OrganizationESMO 2026 Attendance
HU
Hospital Universitario de Navarra
Pamplona, Spain
Cancer centre & hospital
Public university hospital of the Navarre regional health service in Pamplona, Spain.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Satellite
Fri Oct 23
18:15–19:45
Satellite
Fri Oct 23
18:15–18:25
Welcome and introduction
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma
Gastrointestinal cancers
Satellite
Fri Oct 23
18:35–18:45
Selecting your piece: CLDN18.2 targeted therapies
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with The Institute of Cancer Research, Institut Paoli-Calmettes, Hematology Oncology Practice Hamburg
Gastrointestinal cancers
Satellite
Fri Oct 23
18:55–19:10
The emerging picture: Precision medicine in clinical decision-making
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with Hematology Oncology Practice Hamburg, Institut Paoli-Calmettes, The Institute of Cancer Research
Gastrointestinal cancers
Satellite
Fri Oct 23
19:20–19:40
The complete picture: Enhancing patient care
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with Institut Paoli-Calmettes, The Institute of Cancer Research, Hematology Oncology Practice Hamburg
Gastrointestinal cancers
Satellite
Fri Oct 23
19:40–19:45
Symposium summary and close
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma
Gastrointestinal cancers
Poster
Sun Oct 25
12:00–12:45
Petosemtamab plus chemotherapy in metastatic colorectal cancer (mCRC): Updated results from a phase 2 trial
Sunday Poster Display session 4
Gastrointestinal cancers
Satellite
Mon Oct 26
13:00–13:05
Welcome and Introduction
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC
Gastrointestinal cancers
Satellite
Mon Oct 26
13:05–13:20
Evolving Landscape & Unmet Need in Chemorefractory mCRC
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Hospital Universitario de Navarra

Tell us what you sell and we’ll find the people at Hospital Universitario de Navarra most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction